These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 16269308)

  • 1. Preliminary results with early corticosteroid withdrawal in African American renal allograft recipients.
    Gruber SA; West MS; Sillix DH; El-Amm JM; Garnick J; Morawski K; Haririan A
    Surgery; 2005 Oct; 138(4):772-8; discussion 778-9. PubMed ID: 16269308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intermediate-term outcomes with early steroid withdrawal in African-American renal transplant recipients undergoing surveillance biopsy.
    Zeng X; El-Amm JM; Doshi MD; Singh A; Morawski K; Cincotta E; Losanoff JE; West MS; Gruber SA
    Surgery; 2007 Oct; 142(4):538-44; discussion 544-5. PubMed ID: 17950346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early steroid withdrawal therapy in renal transplant recipients: a steroid-free sirolimus and CellCept-based calcineurin inhibitor-minimization protocol.
    Jaber JJ; Feustel PJ; Elbahloul O; Conti AD; Gallichio MH; Conti DJ
    Clin Transplant; 2007; 21(1):101-9. PubMed ID: 17302598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of African-American ethnicity on acute rejection after early steroid withdrawal in primary kidney transplant recipients.
    Padiyar A; Augustine JJ; Bodziak KA; Aeder M; Schulak JA; Hricik DF
    Transplant Proc; 2010 Jun; 42(5):1643-7. PubMed ID: 20620492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early steroid withdrawal protocol with basiliximab, cyclosporine and mycophenolate mofetil in renal-transplant recipients.
    Kato Y; Tojimbara T; Iwadoh K; Koyama I; Nanmoku K; Kai K; Sannomiya A; Nakajima I; Fuchinoue S; Teraoka S
    Int Immunopharmacol; 2006 Dec; 6(13-14):1984-92. PubMed ID: 17161352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Withdrawal of steroid therapy in African American kidney transplant recipients receiving sirolimus and tacrolimus.
    Hricik DE; Knauss TC; Bodziak KA; Weigel K; Rodriguez V; Seaman D; Siegel C; Valente J; Schulak JA
    Transplantation; 2003 Sep; 76(6):938-42. PubMed ID: 14508357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcome predictors in African-American deceased-donor renal allograft recipients.
    Brown KL; El-Amm JM; Doshi MD; Singh A; Cincotta E; Morawski K; Losanoff JE; West MS; Gruber SA
    Clin Transplant; 2009; 23(4):454-61. PubMed ID: 19191806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Avoidance of chronic steroid therapy in african american kidney transplant recipients monitored by surveillance biopsy: 1-year results.
    Anil Kumar MS; Moritz MJ; Saaed MI; Heifets M; Sustento-Reodica N; Fyfe B; Kumar A
    Am J Transplant; 2005 Aug; 5(8):1976-85. PubMed ID: 15996248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes of simultaneous kidney-pancreas transplantation in African-American recipients: a case-control study.
    Lo A; Stratta RJ; Egidi MF; Shokouh-Amiri MH; Grewal HP; Kizilisik AT; Alloway RR; Gaber LW; Gaber AO
    Clin Transplant; 2000 Dec; 14(6):572-9. PubMed ID: 11127311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of four different immunosuppression protocols without long-term steroid therapy in kidney recipients monitored by surveillance biopsy: five-year outcomes.
    Anil Kumar MS; Irfan Saeed M; Ranganna K; Malat G; Sustento-Reodica N; Kumar AM; Meyers WC
    Transpl Immunol; 2008 Nov; 20(1-2):32-42. PubMed ID: 18773960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. African American renal transplant recipients benefit from early corticosteroid withdrawal under modern immunosuppression.
    Boardman RE; Alloway RR; Alexander JW; Buell JF; Cardi M; First MR; Hanaway MT; Munda R; Rogers CC; Roy-Chaudhury P; Susskind B; Trofe J; Woodle ES
    Transplant Proc; 2005 Mar; 37(2):814-6. PubMed ID: 15848541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term graft outcomes after steroid withdrawal in African American kidney transplant recipients receiving sirolimus and tacrolimus.
    Hricik DE; Augustine JJ; Knauss TC; Bodziak KA; Aeder M; Siegel C; Schulak JA
    Transplantation; 2007 Feb; 83(3):277-81. PubMed ID: 17297401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term kidney allograft function and survival in prednisone-free regimens: tacrolimus/mycophenolate mofetil versus tacrolimus/sirolimus.
    Chhabra D; Skaro AI; Leventhal JR; Dalal P; Shah G; Wang E; Gallon L
    Clin J Am Soc Nephrol; 2012 Mar; 7(3):504-12. PubMed ID: 22282478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized trial of thymoglobulin vs. alemtuzumab (with lower dose maintenance immunosuppression) vs. daclizumab in renal transplantation at 24 months of follow-up.
    Ciancio G; Burke GW; Gaynor JJ; Roth D; Kupin W; Rosen A; Cordovilla T; Tueros L; Herrada E; Miller J
    Clin Transplant; 2008; 22(2):200-10. PubMed ID: 18339140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early corticosteroid withdrawal in recipients of renal allografts: a single-center report of ethnically diverse recipients and recipients of marginal deceased-donor kidneys.
    Aull MJ; Dadhania D; Afaneh C; Leeser DB; Hartono C; Lee JB; Serur D; Del Pizzo JJ; Suthanthiran M; Kapur S
    Transplantation; 2012 Oct; 94(8):837-44. PubMed ID: 23001353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcome after steroid withdrawal in pediatric renal transplant patients receiving tacrolimus-based immunosuppression.
    Chakrabarti P; Wong HY; Scantlebury VP; Jordan ML; Vivas C; Ellis D; Lombardozzi-Lane S; Hakala TR; Fung JJ; Simmons RL; Starzl TE; Shapiro R
    Transplantation; 2000 Sep; 70(5):760-4. PubMed ID: 11003353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mycophenolate mofetil for the treatment of a first acute renal allograft rejection: three-year follow-up. The Mycophenolate Mofetil Acute Renal Rejection Study Group.
    Mycophenolate Mofetil Acute Renal Rejection Study Group
    Transplantation; 2001 Apr; 71(8):1091-7. PubMed ID: 11374408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction antibody therapy in renal transplantation using early steroid withdrawal: long-term results comparing anti-IL2 receptor and anti-thymocyte globulin.
    Libório AB; Mendoza TR; Esmeraldo RM; Oliveira ML; Paes FJ; Silva Junior GB; Daher EF
    Int Immunopharmacol; 2011 Nov; 11(11):1832-6. PubMed ID: 21835269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ethnic disparity in clinical outcome after heart transplantation is abrogated using tacrolimus and mycophenolate mofetil-based immunosuppression.
    Mehra MR; Uber PA; Scott RL; Park MH
    Transplantation; 2002 Dec; 74(11):1568-73. PubMed ID: 12490790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Steroid-Sparing and Steroid-Based Immunosuppression in Kidney Transplant: Is There a Difference in Outcomes and Recipient Comorbidities?
    Ahmad N; Khan TFT; Nadeem N; Fourtounas K
    Exp Clin Transplant; 2020 Oct; 18(5):572-576. PubMed ID: 32635885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.